| 摘要 |
A transparent anesthetic solution for intravenous injection comprising at least 55% to 90% propofol dissolved in 10% to 45% of Macrogol 15 Hydroxystearate (SOLUTOL® HS 15), preferably having 25% by weight of Macrogol 15 Hydroxystearate (SOLUTOL® HS 15) for each 10.815 mg/ml of propofol. The solution may also include 0.0515 mg/ml of EDTA for each 10.815 mg/ml of propofol. The compositions result in decreased venous irritation and extends the shelf-life.
|
